Quality-of-life improvements increased from 81% of patients reporting benefit at 12 to 18 months to more than 90% at 30 to 36 months, one of the clearest signals in the dataset that longer treatment ...

A recent study carried out by a research team from the Paul-Ehrlich-Institut investigated the immunomodulating properties of β-glucans. These are natural sugar compounds found in bacteria, fungi and ...

Early introduction of peanut protein reduces allergy prevalence by approximately 80%, with efficacy diminishing as introduction is delayed. Appropriate prevention involves ingestion of approximately 2 ...

Xolair is a branded injectable medication used to treat allergic asthma, chronic hives, and rhinosinusitis. It’s recently been approved to manage food allergies, reducing the risk of serious reactions ...

Please provide your email address to receive an email when new articles are posted on . OMT can be performed by any practicing physician. It works by moving lymphatic fluid and getting rid of any ...

Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the answer to your question in one of our upcoming stories. Our editors also may be in touch with follow-up ...

PHILADELPHIA -- Most multi-food allergic children succeeded in longer term regular dietary consumption whether treated with oral immunotherapy (OIT) or omalizumab (Xolair) alone, results from stage 3 ...

After about six months in his Irish Channel apartment, Allen Clayton started having coughing episodes. He didn’t have a history of asthma and he wasn’t around common triggers like smoke. He was a ...